Drug Evaluation: Clinical Trials

6 trials of Drug Evaluation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6

Follow Drug Evaluation: new trials by email Literature Review of Drug Evaluation trials Research Report on Drug Evaluation

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis
X0002 Spray, Celecoxib capsules, placebo - KNEE OSTEOARTHRITIS
Phase 3CompletedJiangsu XinChen-Techfields Pharma Co., LTD.1802021-09-292023-03-07
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
GB491+ Fulvestrant, Placebo+Fulvestrant - Locally Advanced or Metastatic Breast Cancer
Phase 3CompletedGenor Biopharma Co., Ltd.2752021-09-102024-10-10
Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria
Test Drug (JDP-205), Active Control (Diphenhydramine) - Acute Urticaria
Phase 3CompletedJDP Therapeutics, Inc.2622017-03-012019-11-27
Combined Medication for Improved Analgesia in Superficial Pain
Diclofenac and Atropine combination drug, Placebo - Pain
Phase 3CompletedBrigham and Women's Hospital1002014-04-012018-07-03
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Test group, Reference group - Postmenopausal Women With Osteoporosis
Phase 3CompletedAlvogen Korea2012011-12-012016-11-01
Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis
Zinc, Micronutrient without zinc, Micronutrient with zinc - Tuberculosis
Phase 3CompletedAll India Institute of Medical Sciences4032008-12-012016-02-10

Conditions studied

Breast Neoplasms (1)  ·  Osteoarthritis, Knee (1)  ·  Pain (1)  ·  Tuberculosis (1)

Sponsors

All India Institute of Medical Sciences (1)  ·  Alvogen Korea (1)  ·  Brigham and Women's Hospital (1)  ·  Genor Biopharma Co., Ltd. (1)  ·  JDP Therapeutics, Inc. (1)  ·  Jiangsu XinChen-Techfields Pharma Co., LTD. (1)

Countries

China (2)  ·  United States (2)  ·  Canada (1)  ·  India (1)  ·  South Korea (1)

Top investigators

Binghe Xu, PhD (1)  ·  Moo-il Kang, MD, PhD (1)  ·  Robert R Edwards, PHD (1)  ·  Sushil Kr Kabra, MD (1)

Results publications

PMID 25332327, PMID 28178072, PMID 32653333, PMID 36877132, PMID 39820749